ARCHIVES

Zometa Can Reduce Risk Of Skeletal-Related Events

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

FDA Offers Grants For Conferences

May 1, 1987

Indiana to Close Proton Beam Facility Amid Nationwide Building Boom

October 17, 2014

NCI Launches M-PACT Next-Generation Trial As Group System Nears March 1 Transition

February 21, 2014

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990